FDA panel endorses emergency use authorization for Merck COVID-19 pill - UPI.com
A Food and Drug Administration advisory panel on Tuesday voted to endorse Merck's experimental COVID-19 pill.
The Antimicrobial Drugs Advisory Committee voted 13-10 to recommend emergency use authorization for Merck's molnupiravir oral capsules, the company announced.
"With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine," Dr. Dean Y. Li, executive vice president and president of Merck Research Laboratories, said.
No comments:
Post a Comment